These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3437440

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.
    Brieva JA, Targan S, Stevens RH.
    J Immunol; 1984 Feb; 132(2):611-5. PubMed ID: 6228592
    [Abstract] [Full Text] [Related]

  • 23. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
    Victorino RM, Hodgson HJ.
    Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K, Muliyil JP, Mathai E, Abraham S, Joseph A, Inbamalar U, Aruldas V.
    Natl Med J India; 2001 Jul; 14(1):22-3. PubMed ID: 11242693
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
    Otsuka M, Shiobara S, Harada M, Ueda M, Mori T, Matsue K, Matsuda T.
    Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
    [Abstract] [Full Text] [Related]

  • 31. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.
    Lyanga JJ, Davis P, Thomson AB.
    Clin Exp Immunol; 1979 Jul; 37(1):120-5. PubMed ID: 314871
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
    Kemler BJ, Alpert E.
    Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
    Ginsburg CH, Dambrauskas JT, Ault KA, Falchuk ZM.
    Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
    [Abstract] [Full Text] [Related]

  • 37. Isolation and characterization of cytotoxic effector cells and antibody producing cells from human intestine.
    MacDermott RP.
    Acta Chir Scand Suppl; 1985 Oct; 525():25-43. PubMed ID: 3875204
    [Abstract] [Full Text] [Related]

  • 38. Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients.
    Puissant-Lubrano B, Rostaing L, Kamar N, Abbal M, Fort M, Blancher A.
    Exp Clin Transplant; 2010 Mar; 8(1):19-28. PubMed ID: 20199367
    [Abstract] [Full Text] [Related]

  • 39. Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells.
    Thiele CJ, Stevens RH.
    J Clin Immunol; 1981 Jul; 1(3):174-80. PubMed ID: 6801082
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.